Want to join the conversation?
$XOM 2Q15 Q&A: Mehta of Goldman Sachs asked about production growth post 2017. Jeff answered that based on high quality resource base, XOM has had a significant upstream investment program in place now for extended period where from 2012 to 2017, XOM had committed to its shareholders to 32 high quality long life assets; are halfway through that.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?